Faecal Microbiota Transplant (FMT) For Obesity and Diabetes: A randomised controlled trial in Townsville.

Not Applicable

• Conditions: Obesity; Diabetes II; Diet and Nutrition - Obesity; Metabolic and Endocrine - Diabetes; Oral and Gastrointestinal - Normal oral and gastrointestinal development and function

• Registration Number: ACTRN12616001334493
• Lead Sponsor: Dr Stephen Fairley

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-09-26
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 34

Inclusion Criteria

Aged 18-65 years, able to understand the plain language summary and competent to make informed consent.
Obese (BMI >= 30), features of MetS (central obesity plus at least one of diabetes, HbA1c >6.5% or 48 mmol/mol, hypertension (BP>140/90), dyslipidemia (TG>1.5 mmol/L and/or HDL-Cholesterol <1.0 mmol/l).

Exclusion Criteria

People having,
a) major mental or other illnesses which would preclude consent or affect clinical risk (e.g. cancer diagnosis, known gut polyps).
b) currently taking medication which would affect gut flora (e.g. antibiotics).
c) Pregnant women

Study & Design

• Study Type: Interventional
• Study Design: Not specified